pSivida Corp


The continued advancement of drug delivery technology is critically important in the drive to both increase efficacy and improve patient safety. Furthermore, the use of novel drug delivery systems is an increasingly important strategy for pharmaceutical and biotechnology companies to enable the delivery of new drugs while also extending the commercial life of their current drugs.


pSivida's Durasert Technology is a miniaturized, injectable, sustained-release drug delivery system designed to advance the treatment of medical conditions in critical areas, such as ophthalmology.


Our Durasert Technology enables the development of drug delivery devices that can be:

We have licensed Durasert to Pfizer Inc. for the development stage latanoprost product and to Alimera Sciences for ILUVIEN® products.

pSivida's Tethadur™ Technology is a platform drug delivery system that relies on nano structuring to achieve optimal drug delivery. It can be used alone or in combination with our other technologies.


The Tethadur technology systems have the potential to:

Click here for more information on partnering with pSivida. »